首页> 外文期刊>Oncology reports >Cytotoxicity of herbal extracts used for treatment of prostatic disease on head and neck carcinoma cell lines and non-malignant primary mucosal cells
【24h】

Cytotoxicity of herbal extracts used for treatment of prostatic disease on head and neck carcinoma cell lines and non-malignant primary mucosal cells

机译:草药提取物用于治疗头颈部癌细胞系和非恶性原代黏膜细胞的前列腺疾病的细胞毒性

获取原文
获取原文并翻译 | 示例
       

摘要

Previously, a growth inhibiting effect of PC-Spes on head and neck carcinoma cell lines had been demonstrated. In order to determine the toxic impact of particular herbs in the mixture, we exposed the head and neck cancer cell lines FADU, HLaC79 and its Paclitaxel-resistant subline HLaC79-Clone1 as well as primary mucosal keratinocytes to increasing concentrations of the herbal mixture Prostaprotect, which has a similar formulation as PC-Spes, as well as its single herbal components Dendranthema morifolium, Ganoderma lucidium, Glycyrrhiza glabra, Isatis indigotica, Panax pseudoginseng, Rabdosia rubescens, Scutellaria baicalensis and Pygeum africanum. Growth inhibition was measured using the MTT assay. Expression of P-glycoprotein (P-GP), multidrug resistance protein-1 (MRP-1), multidrug resistance protein-2 (MRP-2), breast cancer resistance protein (BCRP) and androgen receptor (AR) were examined by western blot analysis. Pygeum africanum extract clearly turned out as the main cytotoxic component of the Prostaprotect prescription mixture, and initated apoptosis in sensitive cell lines. All other extracts had only minor toxic effects. Western blot analysis revealed increased expression of P-GP in HLaC79-Clone1 cells, while HLaC79 and FADU cells were negative. All three cell lines were negative for MRP-1 and BCRP but positive for MRP-2. HLaC79 and its descendant HLaC79-Clone1 both expressed AR, as verified by western blotting and immunofluorescence staining. Primary mucosal keratinocytes were negative for all multidrug resistance markers as well as for AR. Growth inhibition rates of the single herbal extracts were compared with previously published results in prostate carcinoma cell lines. The relationship between expression levels of AR and multi-drug resistance markers in relation to the measured toxicity of herbal extracts in our head and neck cancer cell system is critically discussed.
机译:以前,已经证明了PC-Spes对头颈癌细胞系的生长抑制作用。为了确定混合物中特定草药的毒性影响,我们将头颈部癌细胞系FADU,HLaC79及其耐紫杉醇的亚系HLaC79-Clone1以及原发性粘膜角质形成细胞暴露于浓度不断升高的草药混合物Prostaprotect中,它具有与PC-Spes相似的配方,以及其单一草药成分Dendranthema morifolium,灵芝,甘草,板蓝根,三七,人参Rabdosia rubescens,Scutellaria baicalensis和Pygeum africanum。使用MTT测定法测量生长抑制。 Western blot检测P-糖蛋白(P-GP),多药抗性蛋白1(MRP-1),多药抗性蛋白2(MRP-2),乳腺癌抗性蛋白(BCRP)和雄激素受体(AR)的表达。印迹分析。非洲臀果木提取物显然是Prostaprotect处方混合物的主要细胞毒性成分,并在敏感细胞系中引发了细胞凋亡。所有其他提取物仅具有较小的毒性作用。蛋白质印迹分析显示,HLaC79-Clone1细胞中P-GP的表达增加,而HLaC79和FADU细胞为阴性。所有三个细胞系对MRP-1和BCRP均为阴性,但对MRP-2为阳性。经蛋白质印迹和免疫荧光染色验证,HLaC79及其后代HLaC79-Clone1均表达AR。原发性粘膜角质形成细胞对所有多药耐药标志物和AR均呈阴性。将单一草药提取物的生长抑制率与先前在前列腺癌细胞系中发表的结果进行了比较。在我们的头颈癌细胞系统中,AR的表达水平与多药抗性标志物之间的关系与草药提取物的测定毒性有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号